Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Common Stock | Options Exercise | $71.6K | +2.5K | +2.16% | $28.63 | 118K | Jan 3, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Stock Option (Right to Buy) | Options Exercise | $0 | -2.5K | -4.17% | $0.00 | 57.5K | Jan 3, 2023 | Common Stock | 2.5K | $28.63 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. The option vested in full on February 8, 2020. |